Deutsche Bank’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Deutsche Bank’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-68,252	Closed	-$2.27M	–	3760
2024 Q3	$2.27M	Buy	68,252 +54,485	+396%	+$1.88M	﹤0.01%	1671
2024 Q2	$372K	Buy	13,767 +2,549	+23%	+$50.3K	﹤0.01%	2486
2024 Q1	$242K	Buy	+11,218	New	+$245K	﹤0.01%	2733

Deutsche Bank's LBPH Position: Q4 2024 in Review

Deutsche Bank sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 68,252 shares — an estimated $2.27M sold.

Deutsche Bank first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $2.27M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Deutsche Bank reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Deutsche Bank sold 68,252 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $2.27M.
Deutsche Bank first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Deutsche Bank's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $2.27M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Deutsche Bank's 13F filing for Q4 2024, filed 14 Feb 2025.